日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Understanding the aliya pulsed electric field dose-response relationship: Implications for ablation size, thermal load, and immune response in an orthotopic murine breast cancer model.

了解 aliya 脉冲电场剂量反应关系：对原位小鼠乳腺癌模型中消融面积、热负荷和免疫反应的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0318440
Nafie Ebtesam H O, Pastori Chiara, Acharya Rupsa, Kaviani Rosa, Hunter David, Shalaby Waleed, Krimsky William S, Neal Robert E 2nd
免疫/内分泌
乳腺癌
发表日期：2025
文献求助 收藏

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer

曲贝替定单药治疗或联合聚乙二醇化脂质体阿霉素治疗肉瘤和卵巢癌患者的心脏安全性

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3903
Jones, Robin L; Herzog, Thomas J; Patel, Shreyaskumar R; von Mehren, Margaret; Schuetze, Scott M; Van Tine, Brian A; Coleman, Robert L; Knoblauch, Roland; Triantos, Spyros; Hu, Peter; Shalaby, Waleed; McGowan, Tracy; Monk, Bradley J; Demetri, George D
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

Data on prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer: Post-hoc data analysis from the phase 3 randomized, open-label study comparing trabectedin and PLD versus PLD alone in patients with recurrent ovarian cancer

既往聚乙二醇化脂质体阿霉素（PLD）治疗复发性卵巢癌的数据：一项比较曲贝替定联合PLD与单用PLD治疗复发性卵巢癌患者的3期随机、开放标签研究的事后数据分析

期刊:Data in Brief
影响因子:1.4
doi:10.1016/j.dib.2020.105465
Monk, Bradley J; Herzog, Thomas J; Wang, George; Triantos, Spyros; Maul, Scott; Knoblauch, Roland; McGowan, Tracy; Shalaby, Waleed S W; Coleman, Robert L
肿瘤
肿瘤免疫
卵巢癌
发表日期：2020
文献求助 收藏

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

开发和使用一种新型皮下自动注射器，用于注射己酸羟孕酮，以降低复发性早产的风险

期刊:Medical Devices-Evidence and Research
影响因子:1.5
doi:10.2147/MDER.S157114
Travanty, Michael N; Calawa, Bryon; Shalaby, Waleed S; Jozwiakowski, Michael J; Haraldsen, Kyle B
发表日期：2018
文献求助 收藏